Infant Formula Safety Modernization Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing requirements for infant formula products and manufacturing facilities. Manufacturers would be required to test for specified pathogens (including Clostridium botulinum) and report positive results to the FDA within one business day. The bill also mandates that the FDA notify Congress within one business day of receiving positive test results or issuing adverse inspection classifications at infant formula facilities.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.